Global MASH cirrhosis burden is rapidly increasing, yet therapeutic and prognostic frameworks remain limited, with sparse ...

Scientists at Julius Maximilian University of Würzburg have found that rare γδ T cells interact directly with dendritic cells to release interleukin-17, intensifying liver inflammation and fibrosis.

Cirrhotic ascites is driven by proximal tubular sodium reabsorption, mainly via NHE3. Due to spatial coupling of NHE3 and SGLT2, SGLT2 inhibitors ...

Use of sodium-glucose cotransporter-2 inhibitors was linked to significantly reduced risk for adverse kidney, cardiovascular and hepatic outcomes in patients with type 2 diabetes and cirrhosis, ...

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...

Hepatic hydrothorax is a respiratory condition that affects people with cirrhosis and other serious liver issues. It occurs when fluid builds up in the pleural space. Hepatic hydrothorax is a ...

Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology. Researchers examined ...

Liver disease includes any condition that damages your liver. Over time, scar tissue can build up in your liver. Scarring or fibrosis can progress over many years until you develop cirrhosis—the most ...

Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...